Cargando…

Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications

Hepcidin is a crucial peptide for regulating cellular iron efflux. Because iron is essential for cell survival, especially for highly active cells, such as tumor cells, it is imperative to understand how tumor cells manipulate hepcidin expression for their own metabolic needs. Studies suggest that h...

Descripción completa

Detalles Bibliográficos
Autores principales: Vela, Driton, Vela-Gaxha, Zana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903825/
https://www.ncbi.nlm.nih.gov/pubmed/29391539
http://dx.doi.org/10.1038/emm.2017.273
_version_ 1783315002471481344
author Vela, Driton
Vela-Gaxha, Zana
author_facet Vela, Driton
Vela-Gaxha, Zana
author_sort Vela, Driton
collection PubMed
description Hepcidin is a crucial peptide for regulating cellular iron efflux. Because iron is essential for cell survival, especially for highly active cells, such as tumor cells, it is imperative to understand how tumor cells manipulate hepcidin expression for their own metabolic needs. Studies suggest that hepcidin expression and regulation in tumor cells show important differences in comparison with those in non-tumorous cells. These differences should be investigated to develop new strategies to fight cancer cells. Manipulating hepcidin expression to starve cancer cells for iron may prove to be a new therapy in the anticancer arsenal.
format Online
Article
Text
id pubmed-5903825
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-59038252018-04-19 Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications Vela, Driton Vela-Gaxha, Zana Exp Mol Med Review Hepcidin is a crucial peptide for regulating cellular iron efflux. Because iron is essential for cell survival, especially for highly active cells, such as tumor cells, it is imperative to understand how tumor cells manipulate hepcidin expression for their own metabolic needs. Studies suggest that hepcidin expression and regulation in tumor cells show important differences in comparison with those in non-tumorous cells. These differences should be investigated to develop new strategies to fight cancer cells. Manipulating hepcidin expression to starve cancer cells for iron may prove to be a new therapy in the anticancer arsenal. Nature Publishing Group 2018-02 2018-02-02 /pmc/articles/PMC5903825/ /pubmed/29391539 http://dx.doi.org/10.1038/emm.2017.273 Text en Copyright © 2018 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Review
Vela, Driton
Vela-Gaxha, Zana
Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications
title Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications
title_full Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications
title_fullStr Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications
title_full_unstemmed Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications
title_short Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications
title_sort differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903825/
https://www.ncbi.nlm.nih.gov/pubmed/29391539
http://dx.doi.org/10.1038/emm.2017.273
work_keys_str_mv AT veladriton differentialregulationofhepcidinincancerandnoncancertissuesanditsclinicalimplications
AT velagaxhazana differentialregulationofhepcidinincancerandnoncancertissuesanditsclinicalimplications